Dr. Yelda Birinci Kudu, member of Faculty of Medicine, Department of Medical Biochemistry, has been appointed to the “Preclinical Studies of Nanodrugs’’ Working Group of COST Action CA20121 titled “Cancer nanomedicine - from the bench to the bedside (NANO2CLINIC)’’
Istinye University Technology Transfer Office